Publication:
Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?

Simple item page
dc.contributor.authorBILICI, A
dc.contributor.authorUSTAALIOĞLU, BB
dc.contributor.authorERCAN, S
dc.contributor.authorORCUN, A
dc.contributor.authorSeker, MESUT
dc.contributor.authorSALEPCI, T
dc.contributor.authorGUMUS, M
dc.contributor.institutionauthorŞEKER, MESUT
dc.date.accessioned2020-10-29T18:30:32Z
dc.date.available2020-10-29T18:30:32Z
dc.date.issued2011-08-01T00:00:00Z
dc.identifier.citationBILICI A., USTAALIOĞLU B., ERCAN S., ORCUN A., Seker M., SALEPCI T., GUMUS M., -Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?-, Cancer chemotherapy and pharmacology, cilt.68, ss.309-16, 2011
dc.identifier.doi10.1007/s00280-010-1480-0
dc.identifier.scopus79960912819
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25768
dc.identifier.wosWOS:000293133600006
dc.titleIs there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
dc.typeArticle
dspace.entity.typePublication
local.avesis.id4772f454-382e-4d1c-98aa-37074ed2b8fc
local.indexed.atWOS
local.indexed.atScopus
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication8a03684e-e421-4a9f-9069-168fc121a5d4
relation.isAuthorOfPublication.latestForDiscovery8a03684e-e421-4a9f-9069-168fc121a5d4
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Diğer Yayınlar